Geopolitical Tensions Escalate Lebanon Conflict Death Toll Surpasses 3000 Raising Regional Stability Concerns for Markets Yardeni Warns Fed May Need to Raise Rates in July as Bond Vigilantes Pressure Incoming Chair Warsh Jim Cramer Backs Nvidias AI Chip Sales to China Says Stock Can Thrive Either Way Udemy UDMY Q1 2026 Disappoints EPS 021 Below 011 Views Love Factually Dating Startups Target Fake Profiles with Verified Identity Solutions Barclays Warns of Potential Upside Risk to Its 100 Per Barrel Oil Price Forecast for 2026 CBS and Paramount Withdraw Copyright Challenges Following Stephen Colbert Parody Incident Oil Markets Approach Danger Zone as Potential USIran Deal Could Ease Supply Pressure SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags Morrisons to Close 100 Stores Amid Rising Cost Pressures FRAF Q1 2026 Earnings EPS Beats Estimates Stock Declines Health In Tech Inc HIT Q1 2026 Earnings Narrow Loss Beat Expectations Stock Dips 26 on Absent Revenue Details MiNK Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid Clinical Progress Corteva Inc CTVA Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution GIB Q1 2026 Earnings EPS Misses Estimates Slightly Stock Edges Higher Energy Transfer ET Q1 2026 Earnings EPS Miss Slightly Shares Edge Higher Amid Operational Strength Enerpac Tool Group EPAC Edges Higher Consolidation Near Resistance Signals Potential Breakout Eaton Vance RiskManaged Diversified Equity Income Fund ETJ Holds Steady as Support Levels Come into Focus Coeptis Therapeutics Warrants COEPW Hover at 001 in Stagnant Trading Environment BDCIW Holds Steady at 045 A Period of Consolidation for BTC Development Corp Warrant Waste Management WM Slips 11 as Defensive Sector Faces Headwinds Holds Above Key Support agilon health AGL Dips 13 as Shares Consolidate Between Key Support and Resistance US April Payrolls Surprise to the Upside But Economists Flag Underlying Concerns Magnolia Oil Gas Corporation MGY Q1 2026 Earnings Modest EPS Beat Amid Stable Operations Axsome Therapeutics Holds Near Resistance as Biotech Sector Shows Mixed Signals